One of the unintended consequences of IL17 inhibition is a shift from a Th17 to a Th2-dominated immune response, which may explain why some patients develop paradoxical reactions such as eczema-like eruptions or flares of psoriasis. This evidence concerns the gene IL17A and Eczematoid dermatitis.